Skip to content

Author

B. Bhongade

We have 4 of 54 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Diabesity: an old term, a modern challenge — multi-omics and precision anti-obesity pharmacotherapy in type 2 diabetes

Evidence for approved and investigational oral incretin therapies, dual and triple receptor agonists, amylin-based strategies, established antidiabetic drugs, and adjunctive approaches targeting body composition are summarized.

Karolina Hoffmann, Weronika Pucek, Wiktoria Skrzypek et al. · 0 citations
Review Open access Sep 2026

Targeting the Gut–Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone Outcomes

Osteoporosis is a major skeletal disorder. Increasing evidence suggests that gut microbiota-derived mechanisms may contribute to bone remodeling. The biological rationale for a gut–bone axis is well supported, but the clinical relevance of microbiome-targeted interventions remains uncertain. In this narrative review, w...

Sorina Ispas, V. Maggio, A. Wali et al. · 0 citations
Open access Aug 2026

Professional identity, academic satisfaction, and career commitment among undergraduate nursing students in India: a cross-sectional study

Introduction Professional identity, academic satisfaction, and career commitment are important psychological and educational factors that may influence nursing students’ long-term engagement with the nursing profession. In countries such as India, where nursing workforce retention and migration are major concerns, unde...

R. Ravi, Shivani Sharma, Renitha Msj et al. · 0 citations
Review Open access Sep 2026

Pathological Complete Response to Nab-Paclitaxel–Containing Neoadjuvant Regimens in Early Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

Within nab-paclitaxel-containing neoadjuvant backbones, checkpoint-inhibitor addition was associated with higher pCR in randomized comparative evidence, and should not be interpreted as a cross-regimen comparison because of clinical and methodological heterogeneity.

R. A. Salama, M. El-Tanani, S. A. Rabbani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.